Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Haddadin Yezan Munther Create: Alert

All | News | Filings
Date FiledTypeDescription
10/05/2023 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 358,337 options to buy @ $0.24, valued at $86k
03/31/2023 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 41,065 options to buy @ $1.05, valued at $43.1k
10/11/2022 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Bought 29,743 shares @ $1.29, valued at $38.4k
Bought 3,600 shares @ $1.27, valued at $4.6k
10/07/2022 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 71,998 options to buy @ $1.25, valued at $90k
03/24/2022 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 21,878 options to buy @ $1.92, valued at $42k
12/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/26/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/05/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/22/2020 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Bought 10,000 shares @ $0.7245, valued at $7.2k
07/21/2020 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 135,000 options to buy @ $1.58, valued at $213.3k
03/20/2020 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Outlook Therapeutics, Inc.
Txns: Granted 15,000 options to buy @ $0.54, valued at $8.1k
01/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/07/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/02/2017 4 Haddadin Yezan Munther (Director) has filed a Form 4 on Oncobiologics, Inc.
Txns: Granted 25,000 options to buy @ $1.26, valued at $31.5k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy